Andrew J. Stewart

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Bridgewater, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Debra E. Levin, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Andrew J. Stewart

Insider Reports Filed by Andrew J. Stewart

4 BLCO

Bausch & Lomb Corp

Report period
24 Apr 2023
Transactions
1
Transaction value
$0
Accepted by SEC
26 Apr 2023, 17:22
Role
The Reporting Person's title as an officer of the Issuer is President, Ophthalmic Pharmaceuticals.
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .